«And more importantly, we found that if a patient achieves
a complete cytogenetic response, the risk of relapse is the same whether the patient was at low, medium, or high risk when diagnosed,» said Druker.
«Even high - risk patients have close to a 70 percent chance of getting to what we call
a complete cytogenetic response, which is an optimal response to the drug,» said Druker.